SiriusPoint Ltd. reported fourth‑quarter 2025 results that exceeded expectations, delivering net income of $240 million and revenue of $973.7 million, up 18% from the $612.8 million reported in Q4 2024. Full‑year 2025 revenue rose 16% to $3.205 billion, while full‑year net income reached $444 million.
Operating earnings per share for the quarter were $0.70, a 49% increase from the $0.45 reported in Q4 2024 and a $0.16 beat over the consensus estimate of $0.54. The lift was driven by disciplined underwriting, a favorable mix of insurance and reinsurance business, and effective cost control that kept the core combined ratio at 92.9% versus 93.5% in the prior year.
Diluted book value per share grew 28% to $12.30, reflecting the company’s focus on capital efficiency. Leverage fell to 23% of total assets, an all‑time low that the company expects to maintain through the end of February after the redemption of Series B preference shares.
SiriusPoint announced a $100 million share‑repurchase program to be completed over the next 12 months, representing more than 4% of outstanding shares. The program signals management’s confidence in the company’s cash‑generating ability and commitment to returning value to shareholders.
Strategic acquisitions of Assist America and the World Nomads travel‑insurance business are expected to add $8–10 million in annual EBITDA once integrated, while the sale of a 49% stake in Arcadian for $140.4 million and the divestiture of Armada and Arcadian MGAs provide additional liquidity and allow the company to focus on core specialty lines.
Investors reacted positively to the earnings beat and capital‑return initiatives, underscoring confidence in SiriusPoint’s disciplined underwriting, capital management, and growth strategy in a buyer’s market for property‑CAT reinsurance.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.